196 related articles for article (PubMed ID: 38666757)
21. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and natural history of human papillomavirus infections in the female genital tract.
Ault KA
Infect Dis Obstet Gynecol; 2006; 2006 Suppl():40470. PubMed ID: 16967912
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.
Giuliano AR; Tortolero-Luna G; Ferrer E; Burchell AN; de Sanjose S; Kjaer SK; Muñoz N; Schiffman M; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 10(0 10):K17-28. PubMed ID: 18847554
[TBL] [Abstract][Full Text] [Related]
24. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
26. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
28. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
Han JJ; Tarney CM; Song J
Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
[TBL] [Abstract][Full Text] [Related]
29. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions.
Graziottin A; Serafini A
J Sex Med; 2009 Mar; 6(3):633-45. PubMed ID: 19170869
[TBL] [Abstract][Full Text] [Related]
30. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
Ngamkham J; Boonmark K; Phansri T
Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
[TBL] [Abstract][Full Text] [Related]
31. Oral HPV infection: current strategies for prevention and therapy.
Syrjanen S; Termine N; Capra G; Paderni C; Panzarella V; Campisi G
Curr Pharm Des; 2012; 18(34):5452-69. PubMed ID: 22632393
[TBL] [Abstract][Full Text] [Related]
32. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Patel C; Brotherton JM; Pillsbury A; Jayasinghe S; Donovan B; Macartney K; Marshall H
Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326995
[TBL] [Abstract][Full Text] [Related]
33. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
Chelimo C; Wouldes TA; Cameron LD; Elwood JM
J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus.
Vernon SD; Holmes KK; Reeves WC
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S121-4. PubMed ID: 8547501
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus disease in adolescents: management and prevention.
Widdice LE
Adolesc Med State Art Rev; 2012 Apr; 23(1):192-206, xii-xiii. PubMed ID: 22764563
[TBL] [Abstract][Full Text] [Related]
37. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and natural history of HPV.
Cox JT
J Fam Pract; 2006 Nov; Suppl():3-9. PubMed ID: 17366752
[TBL] [Abstract][Full Text] [Related]
39. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
[TBL] [Abstract][Full Text] [Related]
40. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
